Onward Medical N.V. (ONWD) is a Biotechnology company in the Healthcare sector, listed on Euronext Brussel. This page provides the complete earnings calendar, dividend schedule, and financial data for Onward Medical N.V. in 2026. The next earnings report is expected on September 29, 2026.
Next earnings date
29 Sep 2026
In 40 days
EPS estimate
—
Revenue estimate
—
Past earnings
No dividend history available.
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARCEX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer, which restores or enhances physical movement of hand and arm function to people with spinal cord therapy; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord that enables long-paralyzed people to stand and walk again with little or no assistance. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of ARCEX Therapy in restoring strength and function of upper extremities in people with spinal cord injury. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V. (ONWD) is scheduled to report earnings on September 29, 2026.
Onward Medical N.V. (ONWD) last reported earnings on September 2, 2025.
Onward Medical N.V. (ONWD) is listed on Euronext Brussel.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.